Liverpool ECMC retweeted
Today we heard lots of great ideas and had some livery discussions. Now we just need to digest it all and agree our goals and strategies to enhance delivery in the ECMC network. Thanks to all attendees for your input throughout the day 👏
A quick reminder about our open day on Monday 7th October in Chester: join us to learn about clinical trials: what they are, why they're so important for cancer patients. All welcome! Please see our flyer for more information, including how to register. @ECMC_UK @LivUniISMIB
We are holding an open day on Monday 7th October in Chester. Join us to learn about clinical trials: what they are, why they're so important for cancer patients. Everyone is welcome. Please see our flyer for more information, including how to register your attendance.
Liverpool ECMC retweeted
🗣️Calling junior investigators – we're hosting a webinar on exploring career pathways in #ClinicalResearch. Hear from @emmamaryker & @AdamSharpMedOnc sharing their own career journeys & get advice directly from them.
📅17 July 2024
⏰4:00 – 5:00 pm
👉 events.teams.microsoft.com/e…
Day 2 of the Secondary Breast Cancer Patient Summit is underway with talks in the first session on radiotherapy, local therapies, supportive and palliative care @cancermedic @Make2ndsCount @ECMC_UK
Liverpool ECMC retweeted
We're at the Secondary Breast Cancer Summit in Liverpool today - pop over to say hello and learn about the #ECMCnetwork @Make2ndsCount @cancermedic @livecmc @CCCNHS @lesleystephen
Liverpool ECMC retweeted
We are all set to kick off UK’s first meeting specifically for women & men living with secondary breast cancer in Liverpool today.Real good vibe last night amongst attendees. Grateful to all who have made it happen @Make2ndsCount @livecmc @CCCNHS @LesleycStephen @ABCGlobalAll
Liverpool ECMC retweeted
We know how challenging it can be to navigate the secondary breast cancer world of medical terminology & clinical guidelines. Our Summit on 10 & 11 July, will cover a host of relevant topics for the community, friends & family. Register to join online > make2ndscount.co.uk/sbc-summ…
Liverpool ECMC retweeted
Prospective, longitudinal data with a contemporaneous non-cancer cohort has enable us to make important novel observations in regard to cancer patients on treatment & admitted with COVID @LanceTurtle ⬇️ this demonstrates power of national pandemic planning @ISARIC1 @CCPUKstudy
We’re pleased to share our latest analysis of the ISARIC4C CCP-UK dataset of patients hospitalised with COVID in the UK, looking at patients having treatment for cancer over the first two years of the pandemic.
sciencedirect.com/science/ar…
We're pleased to announce that our very own Prof Dan Palmer, Liverpool ECMC Director, is one of five co-Leads of the newly launched GIRFT pancreatic cancer review.
GIRFT is delighted to begin working w/ @PancreaticCanUK on a new national review into #NHS services for #pancreaticcancer patients.
Here's a short little video to tell you more...
Or click the link below for all the details ⬇️
bit.ly/45UxXaP
Liverpool ECMC retweeted
We're ending the week on some great news!
Liverpool's Experimental Cancer Medicine Centre @livecmc has had its funding renewed for the next 5 years to help doctors & scientists find the treatments of the future.
@LivUniISMIB @CCCNHS @livuni_LCTC @CR_UK
news.liverpool.ac.uk/2023/01…
Liverpool ECMC retweeted
Congratulations to @livuniISMIB's & @CCCNHS's Prof Dan Palmer and the team at @livecmc with @CCCNHS & @livuni_LCTC who have secured another 5 years' funding! Read the full story: bit.ly/3XuBA3h
Liverpool ECMC retweeted
Clatterbridge can carry out more pioneering research after an award of up to £1.5m.
@CCCNHS is part of Liverpool’s Experimental Cancer Medicine Centre (ECMC) which will use the money to study cancer treatments of the future over the next 5 years.
See: clatterbridgecc.nhs.uk/news/…
Liverpool ECMC retweeted
New research - Ghaneh et al - Immediate surgery vs short-course neoadjuvant gemcitabine + capecitabine, FOLFIRINOX, or chemoradiotherapy in patients with borderline resectable #pancreaticcancer (ESPAC5)
thelancet.com/journals/langa…
#gitwitter #onctwitter @oncoalert #pancsm

























